1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

International Biotechnology Trust Plc Buys Biogen Inc, Amgen Inc, Insmed Inc, Sells Celgene Corp, Aerie Pharmaceuticals Inc, Alkermes PLC

Investment company International Biotechnology Trust Plc (Current Portfolio) buys Biogen Inc, Amgen Inc, Insmed Inc, Vertex Pharmaceuticals Inc, Neurocrine Biosciences Inc, sells Celgene Corp, Aerie Pharmaceuticals Inc, Alkermes PLC, Enanta Pharmaceuticals Inc, ACADIA Pharmaceuticals Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, International Biotechnology Trust Plc. As of 2019Q2, International Biotechnology Trust Plc owns 63 stocks with a total value of $268 million. These are the details of the buys and sells.

For the details of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's stock buys and sells, go to https://www.gurufocus.com/guru/international+biotechnology+trust+plc/current-portfolio/portfolio

These are the top 5 holdings of INTERNATIONAL BIOTECHNOLOGY TRUST PLC
  1. Gilead Sciences Inc (GILD) - 316,284 shares, 7.97% of the total portfolio. Shares added by 13.66%
  2. Vertex Pharmaceuticals Inc (VRTX) - 85,022 shares, 5.81% of the total portfolio. Shares added by 66.31%
  3. Neurocrine Biosciences Inc (NBIX) - 156,800 shares, 4.94% of the total portfolio. Shares added by 51.35%
  4. Celgene Corp (CELG) - 142,522 shares, 4.91% of the total portfolio. Shares reduced by 39.49%
  5. Alexion Pharmaceuticals Inc (ALXN) - 98,641 shares, 4.82% of the total portfolio. Shares added by 33.95%
New Purchase: Arqule Inc (ARQL)

International Biotechnology Trust Plc initiated holding in Arqule Inc. The purchase prices were between $4.77 and $11.01, with an estimated average price of $6.96. The stock is now traded at around $8.64. The impact to a portfolio due to this purchase was 0.98%. The holding were 239,103 shares as of .

New Purchase: Iovance Biotherapeutics Inc (IOVA)

International Biotechnology Trust Plc initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $9.78 and $24.52, with an estimated average price of $15.03. The stock is now traded at around $20.02. The impact to a portfolio due to this purchase was 0.95%. The holding were 104,000 shares as of .

New Purchase: uniQure NV (QURE)

International Biotechnology Trust Plc initiated holding in uniQure NV. The purchase prices were between $52.76 and $82.19, with an estimated average price of $63.55. The stock is now traded at around $56.02. The impact to a portfolio due to this purchase was 0.8%. The holding were 27,500 shares as of .

New Purchase: Repligen Corp (RGEN)

International Biotechnology Trust Plc initiated holding in Repligen Corp. The purchase prices were between $54.2 and $85.95, with an estimated average price of $67.97. The stock is now traded at around $88.40. The impact to a portfolio due to this purchase was 0.77%. The holding were 24,000 shares as of .

New Purchase: Blueprint Medicines Corp (BPMC)

International Biotechnology Trust Plc initiated holding in Blueprint Medicines Corp. The purchase prices were between $73.54 and $97.8, with an estimated average price of $82.43. The stock is now traded at around $81.73. The impact to a portfolio due to this purchase was 0.6%. The holding were 17,000 shares as of .

New Purchase: Exact Sciences Corp (EXAS)

International Biotechnology Trust Plc initiated holding in Exact Sciences Corp. The purchase prices were between $89.51 and $118.04, with an estimated average price of $100.57. The stock is now traded at around $118.22. The impact to a portfolio due to this purchase was 0.47%. The holding were 10,700 shares as of .

Added: Amgen Inc (AMGN)

International Biotechnology Trust Plc added to a holding in Amgen Inc by 175.00%. The purchase prices were between $166.7 and $195.41, with an estimated average price of $178.91. The stock is now traded at around $199.31. The impact to a portfolio due to this purchase was 2.89%. The holding were 66,000 shares as of .

Added: Biogen Inc (BIIB)

International Biotechnology Trust Plc added to a holding in Biogen Inc by 349.47%. The purchase prices were between $219.29 and $241.72, with an estimated average price of $230.78. The stock is now traded at around $227.63. The impact to a portfolio due to this purchase was 2.89%. The holding were 42,700 shares as of .

Added: Insmed Inc (INSM)

International Biotechnology Trust Plc added to a holding in Insmed Inc by 224.18%. The purchase prices were between $23 and $32.19, with an estimated average price of $27.86. The stock is now traded at around $15.49. The impact to a portfolio due to this purchase was 2.35%. The holding were 356,600 shares as of .

Added: Vertex Pharmaceuticals Inc (VRTX)

International Biotechnology Trust Plc added to a holding in Vertex Pharmaceuticals Inc by 66.31%. The purchase prices were between $164.61 and $190.37, with an estimated average price of $174.67. The stock is now traded at around $181.12. The impact to a portfolio due to this purchase was 2.32%. The holding were 85,022 shares as of .

Added: Neurocrine Biosciences Inc (NBIX)

International Biotechnology Trust Plc added to a holding in Neurocrine Biosciences Inc by 51.35%. The purchase prices were between $72.24 and $91.27, with an estimated average price of $82.02. The stock is now traded at around $94.88. The impact to a portfolio due to this purchase was 1.68%. The holding were 156,800 shares as of .

Added: Exelixis Inc (EXEL)

International Biotechnology Trust Plc added to a holding in Exelixis Inc by 82.12%. The purchase prices were between $18.93 and $24.75, with an estimated average price of $20.95. The stock is now traded at around $19.94. The impact to a portfolio due to this purchase was 1.6%. The holding were 443,534 shares as of .

Sold Out: Aerie Pharmaceuticals Inc (AERI)

International Biotechnology Trust Plc sold out a holding in Aerie Pharmaceuticals Inc. The sale prices were between $28.97 and $48.21, with an estimated average price of $38.56.

Sold Out: Enanta Pharmaceuticals Inc (ENTA)

International Biotechnology Trust Plc sold out a holding in Enanta Pharmaceuticals Inc. The sale prices were between $81.3 and $97.35, with an estimated average price of $89.96.

Sold Out: WAVE Life Sciences Ltd (WVE)

International Biotechnology Trust Plc sold out a holding in WAVE Life Sciences Ltd. The sale prices were between $22.93 and $42.84, with an estimated average price of $27.96.

Sold Out: Array BioPharma Inc (ARRY)

International Biotechnology Trust Plc sold out a holding in Array BioPharma Inc. The sale prices were between $20.84 and $46.58, with an estimated average price of $27.97.

Sold Out: InflaRx NV (IFRX)

International Biotechnology Trust Plc sold out a holding in InflaRx NV. The sale prices were between $3.06 and $51.61, with an estimated average price of $31.98.

Sold Out: Macrogenics Inc (MGNX)

International Biotechnology Trust Plc sold out a holding in Macrogenics Inc. The sale prices were between $14.51 and $19.71, with an estimated average price of $17.19.



Here is the complete portfolio of INTERNATIONAL BIOTECHNOLOGY TRUST PLC. Also check out:

1. INTERNATIONAL BIOTECHNOLOGY TRUST PLC's Undervalued Stocks
2. INTERNATIONAL BIOTECHNOLOGY TRUST PLC's Top Growth Companies, and
3. INTERNATIONAL BIOTECHNOLOGY TRUST PLC's High Yield stocks
4. Stocks that INTERNATIONAL BIOTECHNOLOGY TRUST PLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK